China's precision medicine startup Geneseeq closes $114m Series D round

China's precision medicine startup Geneseeq closes $114m Series D round

Photo: Pixabay

Geneseeq, a Chinese company that develops next-generation sequencing (NGS) for precision medicine, has closed 800 million yuan ($114 million) in a Series D round of financing led by state-owned China Reform Holdings Corporation.